Assessment of financial toxicity in patients with cancer in Slovenia
- PMID: 40445419
- PMCID: PMC12125031
- DOI: 10.1007/s00520-025-09591-7
Assessment of financial toxicity in patients with cancer in Slovenia
Abstract
Purpose: The aim of this study was to assess the extent of financial toxicity in patients with cancer in Slovenia, measured as perceived financial strain and out-of-pocket expenditures.
Methods: The prospective, cross-sectional study was done at Institute of Oncology Ljubljana from June to October 2023. A newly created individual questionnaire was utilized to obtain data on financial toxicity. Patients completed the questionnaire either on paper or online, with or without the assistance of a researcher. The statistical analysis was based on descriptive and inferential statistics.
Results: A total of 901 surveys were disseminated, of which 659 were returned, corresponding to a response rate of 73%. Most patients had compulsory health insurance and were diagnosed in the public healthcare system. Following a cancer diagnosis, 178 (27%) patients reported a decline in financial satisfaction (subjective assessment), while 150 (22.7%) patients observed a change in their financial capability (objective assessment). Younger patients (p < 0.001), female patients (p < 0.004), patients with lower net household income (p < 0.001), and patients who were employed before the diagnosis (p < 0.001) were at a greater risk for financial toxicity. Patients with breast cancer and colorectal, endometrial, skin (including melanoma), esophageal, stomach, kidney, bladder cancers, and lymphoma had higher self-reported subjective and objective financial toxicity than patients with prostate, lung, and head and neck cancer.
Conclusion: This article represents the first comprehensive assessment of financial toxicity among patients with cancer in Slovenia, using perceived financial strain and out-of-pocket expenditures. Most patients reported no significant out-of-pocket costs for the treatment they received. About a quarter of patients with cancer experience financial difficulties.
Keywords: Cancer; Finances; Financial burden; Financial toxicity; Out-of-pocket expenditures; Questionnaire.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval: The study was approved by the Institutional Review Board and Ethical Committee (approval number ERIDNPVO-0031/2023) and by the National Medical Ethics Committee (approval number 0120–105/2023/3). The study complied with the Declaration of Helsinki. Consent to participate: All patients signed an informed consent to participate in the study and to allow processing of their personal data. Competing interests: The authors declare no competing interests. Declaration of generative AI and AI-assisted technologies in the writing process: The authors have nothing to disclose.
Figures



References
-
- Abrams HR, Durbin S, Huang CX et al (2021) Financial toxicity in cancer care: origins, impact, and solutions. Transl Behav Med 11(11):2043–2054 - PubMed
-
- CANCER TODAY: Estimated number of new cases in 2020, World, both Sexex, all Ages (excl. NMSC) [internet]. Lyon: Cancer Today. Available at: https://gco.iarc.fr/today.
-
- Rak v Sloveniji 2020. Ljubljana: Onkološki inštitut Ljubljana, Epidemiologija in register raka. Register raka Republike Slovenije 2023.
MeSH terms
Grants and funding
- J7-4540, P3-0429, P5-0128, P5-0117, P5-0441./Slovenian Research And Innovation Agency (ARIS)
- J7-4540, P3-0429, P5-0128, P5-0117, P5-0441./Slovenian Research And Innovation Agency (ARIS)
- J7-4540, P3-0429, P5-0128, P5-0117, P5-0441./Slovenian Research And Innovation Agency (ARIS)
- J7-4540, P3-0429, P5-0128, P5-0117, P5-0441./Slovenian Research And Innovation Agency (ARIS)
- J7-4540, P3-0429, P5-0128, P5-0117, P5-0441./Slovenian Research And Innovation Agency (ARIS)
LinkOut - more resources
Full Text Sources
Medical